340 Participants Needed

EHR Alert System for Hemorrhagic Stroke

CD
EM
Overseen ByErnst Mayerhofer, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes. The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene.The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.

Who Is on the Research Team?

CD

Christopher D Anderson, MD MMSc

Principal Investigator

Brigham and Women's Hospital

Are You a Good Fit for This Trial?

This trial is for adults over 18 who have had a hemorrhagic stroke and are admitted to the Massachusetts General Hospital inpatient stroke service. It's not open to those with subdural or epidural hematoma, or anyone who doesn't fit the main inclusion criteria.

Inclusion Criteria

I am 18 or older and was admitted to Massachusetts General Hospital for a hemorrhagic stroke.

Exclusion Criteria

Patients not meeting above inclusion criteria
I have a blood clot between my skull and brain or in the outer covering of my brain.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Index Hospitalization

Implementation of EHR-based notification module to increase awareness of risk factors and comorbidities during acute hemorrhagic stroke hospitalization

During hospitalization
In-patient visit

Follow-up

EHR-based notifications for follow-up care, including referrals for sleep study and audiology, and management of LDL and HbA1c levels

6 months
Out-patient visits

Extended Follow-up

Monitoring of LDL and HbA1c measurements over a 12-month period surrounding the stroke event

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • In-patient and out-patient electronic health record alert
Trial Overview The study aims to see if alerting healthcare providers through electronic health records about risk factors and comorbidities can improve management of patients after a hemorrhagic stroke. The focus is on increasing checks for cholesterol (LDL) levels, blood sugar control (HbA1c), sleep apnea, and hearing issues.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Electronic Health Record NotificationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Tufts University

Collaborator

Trials
271
Recruited
595,000+

Boston University

Collaborator

Trials
494
Recruited
9,998,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security